Will GALEN become more RELEVANT?
Lancet Haematol
.
2019 Aug;6(8):e391-e392.
doi: 10.1016/S2352-3026(19)30136-X.
Epub 2019 Jul 8.
Authors
Gottfried von Keudell
1
,
Anas Younes
2
Affiliations
1
Memorial Sloan Kettering Cancer Center, Lymphoma Service, New York, NY 10065, USA.
2
Memorial Sloan Kettering Cancer Center, Lymphoma Service, New York, NY 10065, USA. Electronic address: younesa@mskcc.org.
PMID:
31296424
DOI:
10.1016/S2352-3026(19)30136-X
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal, Humanized
Humans
Lenalidomide*
Lymphoma, B-Cell*
Tomography, X-Ray Computed
Substances
Antibodies, Monoclonal, Humanized
Lenalidomide
obinutuzumab